Serum IL-23 levels reflect a myeloid inflammatory signature and predict the response to apremilast in patients with psoriatic arthritis. - De Santis M; Tonutti A; Isailovic N; Motta F; Rivara RM; Ragusa R; Guidelli GM; Caprioli M; Ceribelli A; Renna D; Luciano N; Selmi C (Frontiers in immunology, 2024)